A limitation of our study is the small sample size (n = 20 for each group) and no validation of the possible effect concerning patient variability on the structure of albumin and the activity of bound antioxidants (e.g. grade and duration of diabetes, other comorbidities). This evidence concerns the gene ALB and diabetes mellitus.